The limited supply of this common reagent is set to drive drug prices higher, but there are ways for companies to lessen the impact.
Biopharma Must Cope With The Fetal Bovine Serum Squeeze Read More »
Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand Read More »
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is “part of a disturbing pattern” of moving regulatory goalposts, according to Clay Alspach, executive director of the Alliance for mRNA Medicines. Meanwhile, streamlined communications with regulators in other countries pave the way for rapid uptake of novel modalities.
Moderna’s mRNA Vaccine Refusal Comes Amid Global Advanced Therapies Push Read More »
BioSpace data show job postings live increased quarter over quarter, while layoffs fell year over year.
2025 Q4 Job Market Report: Positive Signs Emerge for Job Seekers Read More »
Jim O’Neill was deputy secretary at the Department of Health and Human Services and also acting director of the CDC after the abrupt ouster of Susan Monarez in August 2025.
CDC Left Leaderless Again After Acting Director Departs HHS Read More »
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait Read More »
Richard Pazdur had spent 26 years at the FDA before stepping down last year due to disagreements with Commissioner Marty Makary about lowering the number of clinical trials required for a new drug application, Pazdur told the media.
‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements Read More »
The FDA in October 2025 granted bitopertin its Commissioner’s National Priority Voucher but after a shortened review time has decided the data did not support regulatory approval for treating erythropoietic protoporphyria.
FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad’s Skepticism Read More »
España ha vivido en las últimas semanas episodios de lluvias torrenciales que, además de inundaciones puntuales, han demostrado las limitaciones de infraestructuras hídricas diseñadas para un clima más estable. Las lluvias extremas son ya un fenómeno …
Noticias de la actualidad astronómica y astronáutica del 16 de febrero de 2026. …
